Map Heart News Today

HeartCare Combines Testing Using Both AlloMap Gene Expression Profiling and AlloSure Donor-Derived Cell-Free DNA ...

By Chris Wack CareDx shares were up 10% to $11.58 after Medicare approved coverage for HeartCare, a testing service that includes both AlloMap Heart and...

Operator Greetings, and welcome to the CareDx, Inc. Fourth Quarter 2020 Earnings Conference Call. [Operator Instructions] I would now like to turn the conference over to your host, Greg Chodaczek, Managing Director. Greg Chodaczek -- Investor Relations Good afternoon, and thank you for joining us today. Earlier today, CareDx released financial results for the quarter and year ended December 31, 2020. The release is currently available on the Companys website at www.caredx.com. Reg Seeto, Chief...